Furthermore, UBE2S exerted an impact on the pathogenesis of malignancy and radiotherapy resistance in gliomas and was identified as a significant prognostic factor for unfavorable survival outcomes in patients with low-grade gliomas [71]. This evidence concerns the gene UBE2S and central nervous system cancer.